Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2020-12-14
2021-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Moringa Powder Acceptability Trial Among Healthy Adults
NCT05861076
Effect of Ishige Okamurae Extract on Musculoskeletal Biomarkers in Adults With Relative Sarcopenia
NCT04617951
Effects of a Supplement on Acute Respiratory Infections
NCT02210156
The Effects of Chicken Extract on Mental Energy in Healthy Adults and the Underlying Mechanisms
NCT06021223
Botanical Supplement Muscle Function and Lean Body Mass
NCT03034668
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bronch™ group
2 times a day, 1 pill for 1 time, after breakfast/dinner meal(1,600 mg/day, 800 mg/day as Bronch™)
Bronch™
2 times a day, 1 pill for 1 time, after breakfast/dinner meal, for 12 week
Placebo group
2 times a day, 1 pill for 1 time, after breakfast/dinner meal(1,600 mg/day)
placebo
2 times a day, 1 pill for 1 time, after breakfast/dinner meal, for 12 week
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bronch™
2 times a day, 1 pill for 1 time, after breakfast/dinner meal, for 12 week
placebo
2 times a day, 1 pill for 1 time, after breakfast/dinner meal, for 12 week
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* nonsmoker
* After fully hearing and fully understanding this clinical trials, those who agree to voluntarily decide to participate and to comply with the notice
Exclusion Criteria
* Participants who have Body Mass Index(BMI) less than 18.5 kg/m\^2 or more than 35 kg/m\^2
* Participants who have taken medication or dietary supplements related to the respiratory disease within 1 months prior to screening
* Participants with a history of antipsychotic medication use within 3 months prior to the screening examination
* Participants who alcoholic or drug abuse suspected
* Participants who have participated in the other human trials within 3 months before the screening test
* Laboratory test by show the following results
* AST, ALT \> Reference range 3 times upper limit
* Serum Creatinine \> 2.0 mg/dL
* Pregnancy or breast feeding
* Patients who are judged ineligible to participate in the trial by the principal investigator for other reasons, including laboratory test outcomes
19 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chonbuk National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Soo-Wan Chae
Principal investigator, Clinical Trial Center for Functional Foods
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinical Trial Center for Functional Foods Chonbuk National University Hospital
Jeonju, Jeollabuk-do, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NS_Bronch_01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.